Abstract
Intracellular Ca2+ signaling regulates a plethora of cellular functions. A central role in these processes is reserved for the inositol 1,4,5-trisphosphate receptor (IP3R), a ubiquitously expressed Ca2+-release channel, mainly located in the endoplasmic reticulum (ER). Three IP3R isoforms (IP3R1, IP3R2 and IP3R3) exist, encoded respectively by ITPR1, ITPR2 and ITPR3. The proteins encoded by these genes are each about 2700 amino acids long and assemble into large tetrameric channels, which form the target of many regulatory proteins, including several tumor suppressors and oncogenes. Due to the important role of the IP3Rs in cell function, their dysregulation is linked to multiple pathologies. In this review, we highlight the complex role of the IP3R in cancer, as it participates in most of the so-called “hallmarks of cancer”. In particular, the IP3R directly controls cell death and cell survival decisions via regulation of autophagy and apoptosis. Moreover, the IP3R impacts cellular proliferation, migration and invasion. Typical examples of the role of the IP3Rs in these various processes are discussed. The relative levels of the IP3R isoforms expressed and their subcellular localization, e.g. at the ER-mitochondrial interface, is hereby important. Finally, evidence is provided about how the knowledge of the regulation of the IP3R by tumor suppressors and oncogenes can be exploited to develop novel therapeutic approaches to fight cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AMPK:
-
Adenosine monophosphate-activated protein kinase
- APAF1:
-
Apoptotic protease-activating factor 1
- ARM:
-
Armadillo solenoid fold
- ATG:
-
Autophagy-related
- BKCa Channel:
-
large conductance Ca2+-activated K+ channel
- ER:
-
Endoplasmic reticulum
- IICR:
-
IP3-induced Ca2+ release
- IP3:
-
Inositol 1,4,5-trisphosphate
- IP3R:
-
Inositol 1,4,5-trisphosphate receptor
- ITPR:
-
Inositol 1,4,5-trisphosphate receptor gene
- MOMP:
-
Mitochondrial outer membrane permeabilization
- mPTP:
-
Mitochondrial permeability transition pore
- mTORC1:
-
Mechanistic target of rapamycin complex 1
- ROS:
-
Reactive oxygen species
- SMAC:
-
Second mitochondria-derived activator of caspases
- SOCE:
-
Store-operated Ca2+ entry
- XIAP:
-
X-linked inhibitor of apoptosis protein
References
Akl H, Monaco G, La Rovere R, Welkenhuyzen K, Kiviluoto S et al (2013) IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2. Cell Death Dis 4:e632. https://doi.org/10.1038/cddis.2013.140
Akl H, La Rovere RM, Janssens A, Vandenberghe P, Parys JB et al (2015) HA14-1 potentiates apoptosis in B-cell cancer cells sensitive to a peptide disrupting IP3 receptor/Bcl-2 complexes. Int J Dev Biol 59(7–9):391–398. https://doi.org/10.1387/ijdb.150213gb
Alonso MT, Garcia-Sancho J (2011) Nuclear Ca2+ signalling. Cell Calcium 49(5):280–289. https://doi.org/10.1016/j.ceca.2010.11.004
Alzayady KJ, Wang L, Chandrasekhar R, Wagner LE II, Van Petegem F et al (2016) Defining the stoichiometry of inositol 1,4,5-trisphosphate binding required to initiate Ca2+ release. Sci Signal 9(422):ra35. https://doi.org/10.1126/scisignal.aad6281
Arrington AK, Heinrich EL, Lee W, Duldulao M, Patel S et al (2012) Prognostic and predictive roles of KRAS mutation in colorectal cancer. Int J Mol Sci 13(10):12153–12168. https://doi.org/10.3390/ijms131012153
Atakpa P, Thillaiappan NB, Mataragka S, Prole DL, Taylor CW (2018) IP3 receptors preferentially associate with ER-lysosome contact sites and selectively deliver Ca2+ to lysosomes. Cell Rep 25(11):3180–3193 e7. https://doi.org/10.1016/j.celrep.2018.11.064
Azumaya CM, Linton EA, Risener CJ, Nakagawa T, Karakas E (2020) Cryo-EM structure of human type-3 inositol triphosphate receptor reveals the presence of a self-binding peptide that acts as an antagonist. J Biol Chem 295(6):1743–1753. https://doi.org/10.1074/jbc.RA119.011570
Barnhart BC, Alappat EC, Peter ME (2003) The CD95 type I/type II model. Semin Immunol 15(3):185–193. https://doi.org/10.1016/s1044-5323(03)00031-9
Bartok A, Weaver D, Golenar T, Nichtova Z, Katona M et al (2019) IP3 receptor isoforms differently regulate ER-mitochondrial contacts and local calcium transfer. Nat Commun 10(1):3726. https://doi.org/10.1038/s41467-019-11646-3
Berridge MJ (2016) The inositol trisphosphate/calcium signaling pathway in health and disease. Physiol Rev 96(4):1261–1296. https://doi.org/10.1152/physrev.00006.2016
Berridge MJ, Lipp P, Bootman MD (2000) The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1(1):11–21. https://doi.org/10.1038/35036035
Bittremieux M, Parys JB, Pinton P, Bultynck G (2016) ER functions of oncogenes and tumor suppressors: Modulators of intracellular Ca2+ signaling. Biochim Biophys Acta 1863(6 Pt B):1364–1378. https://doi.org/10.1016/j.bbamcr.2016.01.002
Bittremieux M, La Rovere RM, Akl H, Martines C, Welkenhuyzen K et al (2019) Constitutive IP3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP3 receptor disruptor BIRD-2. Cell Death Differ 26(3):531–547. https://doi.org/10.1038/s41418-018-0142-3
Blackshaw S, Sawa A, Sharp AH, Ross CA, Snyder SH et al (2000) Type 3 inositol 1,4,5-trisphosphate receptor modulates cell death. FASEB J 14(10):1375–1379. https://doi.org/10.1096/fj.14.10.1375
Boehning D, Patterson RL, Sedaghat L, Glebova NO, Kurosaki T et al (2003) Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol 5(12):1051–1061. https://doi.org/10.1038/ncb1063
Bong AHL, Monteith GR (2018) Calcium signaling and the therapeutic targeting of cancer cells. Biochim Biophys Acta Mol Cell Res 1865(11 Pt B):1786–1794. https://doi.org/10.1016/j.bbamcr.2018.05.015
Bootman MD, Bultynck G (2020) Fundamentals of cellular calcium signaling: a primer. Cold Spring Harb Perspect Biol 12(1):a038802. https://doi.org/10.1101/cshperspect.a038802
Bootman MD, Chehab T, Bultynck G, Parys JB, Rietdorf K (2018) The regulation of autophagy by calcium signals: Do we have a consensus? Cell Calcium 70:32–46. https://doi.org/10.1016/j.ceca.2017.08.005
Bosanac I, Alattia JR, Mal TK, Chan J, Talarico S et al (2002) Structure of the inositol 1,4,5-trisphosphate receptor binding core in complex with its ligand. Nature 420(6916):696–700. https://doi.org/10.1038/nature01268
Bosanac I, Yamazaki H, Matsu-Ura T, Michikawa T, Mikoshiba K et al (2005) Crystal structure of the ligand binding suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor. Mol Cell 17(2):193–203. https://doi.org/10.1016/j.molcel.2004.11.047
Cardenas C, Miller RA, Smith I, Bui T, Molgó J et al (2010) Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell 142(2):270–283. https://doi.org/10.1016/j.cell.2010.06.007
Cardenas C, Muller M, McNeal A, Lovy A, Jana F et al (2016) Selective vulnerability of cancer cells by inhibition of Ca2+ transfer from endoplasmic reticulum to mitochondria. Cell Rep 14(10):2313–2324. https://doi.org/10.1016/j.celrep.2016.02.030
Carroll J, He J, Ding S, Fearnley IM, Walker JE (2019) Persistence of the permeability transition pore in human mitochondria devoid of an assembled ATP synthase. Proc Natl Acad Sci U S A 116(26):12816–12821. https://doi.org/10.1073/pnas.1904005116
Chen JJ, Boehning D (2017) Protein lipidation as a regulator of apoptotic calcium release: relevance to cancer. Front Oncol 7:138. https://doi.org/10.3389/fonc.2017.00138
Csordas G, Thomas AP, Hajnoczky G (1999) Quasi-synaptic calcium signal transmission between endoplasmic reticulum and mitochondria. EMBO J 18(1):96–108. https://doi.org/10.1093/emboj/18.1.96
Cui C, Merritt R, Fu L, Pan Z (2017) Targeting calcium signaling in cancer therapy. Acta Pharm Sin B 7(1):3–17. https://doi.org/10.1016/j.apsb.2016.11.001
Decuypere JP, Bultynck G, Parys JB (2011a) A dual role for Ca2+ in autophagy regulation. Cell Calcium 50(3):242–250. https://doi.org/10.1016/j.ceca.2011.04.001
Decuypere JP, Welkenhuyzen K, Luyten T, Ponsaerts R, Dewaele M et al (2011b) Ins(1,4,5)P3 receptor-mediated Ca2+ signaling and autophagy induction are interrelated. Autophagy 7(12):1472–1489. https://doi.org/10.4161/auto.7.12.17909
Dubois C, Prevarskaya N, Vanden Abeele F (2016) The calcium-signaling toolkit: updates needed. Biochim Biophys Acta 1863(6 Pt B):1337–1343. https://doi.org/10.1016/j.bbamcr.2015.11.033
Eskelinen EL (2011) The dual role of autophagy in cancer. Curr Opin Pharmacol 11(4):294–300. https://doi.org/10.1016/j.coph.2011.03.009
Feriod CN, Oliveira AG, Guerra MT, Nguyen L, Richards KM et al (2017) Hepatic inositol 1,4,5 trisphosphate receptor type 1 mediates fatty liver. Hepatol Commun 1(1):23–35. https://doi.org/10.1002/hep4.1012
Foskett JK, White C, Cheung KH, Mak DO (2007) Inositol trisphosphate receptor Ca2+ release channels. Physiol Rev 87(2):593–658. https://doi.org/10.1152/physrev.00035.2006
Fredericks GJ, Hoffmann FW, Rose AH, Osterheld HJ, Hess FM et al (2014) Stable expression and function of the inositol 1,4,5-triphosphate receptor requires palmitoylation by a DHHC6/selenoprotein K complex. Proc Natl Acad Sci U S A 111(46):16478–16483. https://doi.org/10.1073/pnas.1417176111
Galluzzi L, Vanpouille-Box C (2018) BAX and BAK at the gates of innate immunity. Trends Cell Biol 28(5):343–345. https://doi.org/10.1016/j.tcb.2018.02.010
Gambardella J, Lombardi A, Morelli MB, Ferrara J, Santulli G (2020) Inositol 1,4,5-trisphosphate receptors in human disease: a comprehensive update. J Clin Med 9(4):1096. https://doi.org/10.3390/jcm9041096
Giacomello M, Drago I, Bortolozzi M, Scorzeto M, Gianelle A et al (2010) Ca2+ hot spots on the mitochondrial surface are generated by Ca2+ mobilization from stores, but not by activation of store-operated Ca2+ channels. Mol Cell 38(2):280–290. https://doi.org/10.1016/j.molcel.2010.04.003
Giorgio V, Burchell V, Schiavone M, Bassot C, Minervini G et al (2017) Ca2+ binding to F-ATP synthase β subunit triggers the mitochondrial permeability transition. EMBO Rep 18(7):1065–1076. https://doi.org/10.15252/embr.201643354
Gordon PB, Holen I, Fosse M, Rotnes JS, Seglen PO (1993) Dependence of hepatocytic autophagy on intracellularly sequestered calcium. J Biol Chem 268(35):26107–26112
Greenberg EF, McColl KS, Zhong F, Wildey G, Dowlati A et al (2015) Synergistic killing of human small cell lung cancer cells by the Bcl-2-inositol 1,4,5-trisphosphate receptor disruptor BIRD-2 and the BH3-mimetic ABT-263. Cell Death Dis 6:e2034. https://doi.org/10.1038/cddis.2015.355
Guerra MT, Florentino RM, Franca A, Lima Filho AC, Dos Santos ML et al (2019) Expression of the type 3 InsP3 receptor is a final common event in the development of hepatocellular carcinoma. Gut 68(9):1676–1687. https://doi.org/10.1136/gutjnl-2018-317811
Hamada K, Miyatake H, Terauchi A, Mikoshiba K (2017) IP3-mediated gating mechanism of the IP3 receptor revealed by mutagenesis and X-ray crystallography. Proc Natl Acad Sci U S A 114(18):4661–4666. https://doi.org/10.1073/pnas.1701420114
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. https://doi.org/10.1016/j.cell.2011.02.013
Higo T, Hattori M, Nakamura T, Natsume T, Michikawa T et al (2005) Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44. Cell 120(1):85–98. https://doi.org/10.1016/j.cell.2004.11.048
Hisatsune C, Mikoshiba K (2017) IP3 receptor mutations and brain diseases in human and rodents. J Neurochem 141(6):790–807. https://doi.org/10.1111/jnc.13991
Hohendanner F, McCulloch AD, Blatter LA, Michailova AP (2014) Calcium and IP3 dynamics in cardiac myocytes: experimental and computational perspectives and approaches. Front Pharmacol 5:35. https://doi.org/10.3389/fphar.2014.00035
Høyer-Hansen M, Bastholm L, Szyniarowski P, Campanella M, Szabadkai G et al (2007) Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-β, and Bcl-2. Mol Cell 25(2):193–205. https://doi.org/10.1016/j.molcel.2006.12.009
Hu YX, Han XS, Jing Q (2019) Ca2+ ion and autophagy. Adv Exp Med Biol 1206:151–166. https://doi.org/10.1007/978-981-15-0602-4_7
Huang X, Jin M, Chen YX, Wang J, Zhai K et al (2016) ERP44 inhibits human lung cancer cell migration mainly via IP3R2. Aging (Albany NY) 8(6):1276–1286. https://doi.org/10.18632/aging.100984
Humeau J, Bravo-San Pedro JM, Vitale I, Nunez L, Villalobos C et al (2018) Calcium signaling and cell cycle: progression or death. Cell Calcium 70:3–15. https://doi.org/10.1016/j.ceca.2017.07.006
Hwang MS, Schwall CT, Pazarentzos E, Datler C, Alder NN et al (2014) Mitochondrial Ca2+ influx targets cardiolipin to disintegrate respiratory chain complex II for cell death induction. Cell Death Differ 21(11):1733–1745. https://doi.org/10.1038/cdd.2014.84
Ivanova H, Vervliet T, Missiaen L, Parys JB, De Smedt H et al (2014) Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival. Biochim Biophys Acta 1843(10):2164–2183. https://doi.org/10.1016/j.bbamcr.2014.03.007
Ivanova H, Vervliet T, Monaco G, Terry LE, Rosa N et al (2020) Bcl-2-protein family as modulators of IP3 receptors and other organellar Ca2+ channels. Cold Spring Harb Perspect Biol 12(4):a035089. https://doi.org/10.1101/cshperspect.a035089
Iwai M, Michikawa T, Bosanac I, Ikura M, Mikoshiba K (2007) Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors. J Biol Chem 282(17):12755–12764. https://doi.org/10.1074/jbc.M609833200
Kale J, Osterlund EJ, Andrews DW (2018) BCL-2 family proteins: changing partners in the dance towards death. Cell Death Differ 25(1):65–80. https://doi.org/10.1038/cdd.2017.186
Kania E, Roest G, Vervliet T, Parys JB, Bultynck G (2017) IP3 receptor-mediated calcium signaling and its role in autophagy in cancer. Front Oncol 7:140. https://doi.org/10.3389/fonc.2017.00140
Kerkhofs M, Seitaj B, Ivanova H, Monaco G, Bultynck G et al (2018) Pathophysiological consequences of isoform-specific IP3 receptor mutations. Biochim Biophys Acta Mol Cell Res 1865(11 Pt B):1707–1717. https://doi.org/10.1016/j.bbamcr.2018.06.004
Kilpatrick BS, Eden ER, Schapira AH, Futter CE, Patel S (2013) Direct mobilisation of lysosomal Ca2+ triggers complex Ca2+ signals. J Cell Sci 126(Pt 1):60–66. https://doi.org/10.1242/jcs.118836
La Rovere RM, Roest G, Bultynck G, Parys JB (2016) Intracellular Ca2+ signaling and Ca2+ microdomains in the control of cell survival, apoptosis and autophagy. Cell Calcium 60(2):74–87. https://doi.org/10.1016/j.ceca.2016.04.005
Lam D, Kosta A, Luciani MF, Golstein P (2008) The inositol 1,4,5-trisphosphate receptor is required to signal autophagic cell death. Mol Biol Cell 19(2):691–700. https://doi.org/10.1091/mbc.e07-08-0823
Lavik AR, Zhong F, Chang MJ, Greenberg E, Choudhary Y et al (2015) A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2. Oncotarget 6(29):27388–27402. https://doi.org/10.18632/oncotarget.4489
Lewis RS (2020) Store-operated calcium channels: from function to structure and back again. Cold Spring Harb Perspect Biol 12(5):a035055. https://doi.org/10.1101/cshperspect.a035055
Liu EY, Ryan KM (2012) Autophagy and cancer--issues we need to digest. J Cell Sci 125(Pt 10):2349–2358. https://doi.org/10.1242/jcs.093708
Liu AJ, Wang SH, Chen KC, Kuei HP, Shih YL et al (2013) Evodiamine, a plant alkaloid, induces calcium/JNK-mediated autophagy and calcium/mitochondria-mediated apoptosis in human glioblastoma cells. Chem Biol Interact 205(1):20–28. https://doi.org/10.1016/j.cbi.2013.06.004
Lock JT, Smith IF, Parker I (2019) Spatial-temporal patterning of Ca2+ signals by the subcellular distribution of IP3 and IP3 receptors. Semin Cell Dev Biol 94:3–10. https://doi.org/10.1016/j.semcdb.2019.01.012
Lopez-Sanjurjo CI, Tovey SC, Prole DL, Taylor CW (2013) Lysosomes shape Ins(1,4,5)P3-evoked Ca2+ signals by selectively sequestering Ca2+ released from the endoplasmic reticulum. J Cell Sci 126(Pt 1):289–300. https://doi.org/10.1242/jcs.116103
Luyten T, Welkenhuyzen K, Roest G, Kania E, Wang L et al (2017) Resveratrol-induced autophagy is dependent on IP3Rs and on cytosolic Ca2+. Biochim Biophys Acta, Mol Cell Res 1864(6):947–956. https://doi.org/10.1016/j.bbamcr.2017.02.013
Mendes CC, Gomes DA, Thompson M, Souto NC, Goes TS et al (2005) The type III inositol 1,4,5-trisphosphate receptor preferentially transmits apoptotic Ca2+ signals into mitochondria. J Biol Chem 280(49):40892–40900. https://doi.org/10.1074/jbc.M506623200
Messai Y, Noman MZ, Hasmim M, Janji B, Tittarelli A et al (2014) ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy. Cancer Res 74(23):6820–6832. https://doi.org/10.1158/0008-5472.CAN-14-0303
Monteith GR, Prevarskaya N, Roberts-Thomson SJ (2017) The calcium-cancer signalling nexus. Nat Rev Cancer 17(6):367–380. https://doi.org/10.1038/nrc.2017.18
Morciano G, Marchi S, Morganti C, Sbano L, Bittremieux M et al (2018) Role of mitochondria-associated ER membranes in calcium regulation in cancer-specific settings. Neoplasia 20(5):510–523. https://doi.org/10.1016/j.neo.2018.03.005
Morgan AJ, Davis LC, Wagner SK, Lewis AM, Parrington J et al (2013) Bidirectional Ca2+ signaling occurs between the endoplasmic reticulum and acidic organelles. J Cell Biol 200(6):789–805. https://doi.org/10.1083/jcb.201204078
Mound A, Rodat-Despoix L, Bougarn S, Ouadid-Ahidouch H, Matifat F (2013) Molecular interaction and functional coupling between type 3 inositol 1,4,5-trisphosphate receptor and BKCa channel stimulate breast cancer cell proliferation. Eur J Cancer 49(17):3738–3751. https://doi.org/10.1016/j.ejca.2013.07.013
Mound A, Vautrin-Glabik A, Foulon A, Botia B, Hague F et al (2017) Downregulation of type 3 inositol (1,4,5)-trisphosphate receptor decreases breast cancer cell migration through an oscillatory Ca2+ signal. Oncotarget 8(42):72324–72341. https://doi.org/10.18632/oncotarget.20327
Okeke E, Parker T, Dingsdale H, Concannon M, Awais M et al (2016) Epithelial-mesenchymal transition, IP3 receptors and ER-PM junctions: translocation of Ca2+ signalling complexes and regulation of migration. Biochem J 473(6):757–767. https://doi.org/10.1042/BJ20150364
Paknejad N, Hite RK (2018) Structural basis for the regulation of inositol trisphosphate receptors by Ca2+ and IP3. Nat Struct Mol Biol 25(8):660–668. https://doi.org/10.1038/s41594-018-0089-6
Parys JB, De Smedt H (2012) Inositol 1,4,5-trisphosphate and its receptors. Adv Exp Med Biol 740:255–279. https://doi.org/10.1007/978-94-007-2888-2_11
Parys JB, Vervliet T (2020) New insights in the IP3 receptor and its regulation. Adv Exp Med Biol 1131:243–270. https://doi.org/10.1007/978-3-030-12457-1_10
Parys JB, Decuypere JP, Bultynck G (2012) Role of the inositol 1,4,5-trisphosphate receptor/Ca2+-release channel in autophagy. Cell Commun Signal 10(1):17. https://doi.org/10.1186/1478-811X-10-17
Pierro C, Cook SJ, Foets TC, Bootman MD, Roderick HL (2014) Oncogenic K-Ras suppresses IP3-dependent Ca2+ release through remodelling of the isoform composition of IP3Rs and ER luminal Ca2+ levels in colorectal cancer cell lines. J Cell Sci 127(Pt 7):1607–1619. https://doi.org/10.1242/jcs.141408
Pierro C, Zhang X, Kankeu C, Trebak M, Bootman MD et al (2018) Oncogenic KRAS suppresses store-operated Ca2+ entry and ICRAC through ERK pathway-dependent remodelling of STIM expression in colorectal cancer cell lines. Cell Calcium 72:70–80. https://doi.org/10.1016/j.ceca.2018.03.002
Pierro C, Sneyers F, Bultynck G, Roderick HL (2019) ER Ca2+ release and store-operated Ca2+ entry - partners in crime or independent actors in oncogenic transformation? Cell Calcium 82:102061. https://doi.org/10.1016/j.ceca.2019.102061
Prevarskaya N, Skryma R, Shuba Y (2018) Ion channels in cancer: are cancer hallmarks oncochannelopathies? Physiol Rev 98(2):559–621. https://doi.org/10.1152/physrev.00044.2016
Prole DL, Taylor CW (2016) Inositol 1,4,5-trisphosphate receptors and their protein partners as signalling hubs. J Physiol 594(11):2849–2866. https://doi.org/10.1113/JP271139
Prole DL, Taylor CW (2019) Structure and function of IP3 receptors. Cold Spring Harb Perspect Biol 11(4):a035063. https://doi.org/10.1101/cshperspect.a035063
Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M et al (2010) Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 90(4):1383–1435. https://doi.org/10.1152/physrev.00030.2009
Rezuchova I, Hudecova S, Soltysova A, Matuskova M, Durinikova E et al (2019) Type 3 inositol 1,4,5-trisphosphate receptor has antiapoptotic and proliferative role in cancer cells. Cell Death Dis 10(3):186. https://doi.org/10.1038/s41419-019-1433-4
Rizzuto R, Brini M, Murgia M, Pozzan T (1993) Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science 262(5134):744–747. https://doi.org/10.1126/science.8235595
Roberts-Thomson SJ, Chalmers SB, Monteith GR (2019) The calcium-signaling toolkit in cancer: remodeling and targeting. Cold Spring Harb Perspect Biol 11(8):a035204. https://doi.org/10.1101/cshperspect.a035204
Roderick HL, Cook SJ (2008) Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat Rev Cancer 8(5):361–375. https://doi.org/10.1038/nrc2374
Rong YP, Aromolaran AS, Bultynck G, Zhong F, Li X et al (2008) Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2’s inhibition of apoptotic calcium signals. Mol Cell 31(2):255–265. https://doi.org/10.1016/j.molcel.2008.06.014
Rosa N, Sneyers F, Parys JB, Bultynck G (2020) Type 3 IP3 receptors: the chameleon in cancer. Int Rev Cell Mol Biol 351:101–148. https://doi.org/10.1016/bs.ircmb.2020.02.003
Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F et al (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17(6):1675–1687. https://doi.org/10.1093/emboj/17.6.1675
Serysheva II, Baker MR, Fan G (2017) Structural insights into IP3R function. Adv Exp Med Biol 981:121–147. https://doi.org/10.1007/978-3-319-55858-5_6
Shibao K, Fiedler MJ, Nagata J, Minagawa N, Hirata K et al (2010) The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma. Cell Calcium 48(6):315–323. https://doi.org/10.1016/j.ceca.2010.09.005
Singh A, Chagtoo M, Tiwari S, George N, Chakravarti B et al (2017a) Inhibition of inositol 1, 4, 5-trisphosphate receptor induce breast cancer cell death through deregulated autophagy and cellular bioenergetics. J Cell Biochem 118(8):2333–2346. https://doi.org/10.1002/jcb.25891
Singh A, Sharma RK, Chagtoo M, Agarwal G, George N et al (2017b) 1H NMR metabolomics reveals association of high expression of inositol 1, 4, 5 trisphosphate receptor and metabolites in breast cancer patients. PLoS One 12(1):e0169330. https://doi.org/10.1371/journal.pone.0169330
Singh R, Letai A, Sarosiek K (2019) Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol 20(3):175–193. https://doi.org/10.1038/s41580-018-0089-8
Smaili SS, Pereira GJ, Costa MM, Rocha KK, Rodrigues L et al (2013) The role of calcium stores in apoptosis and autophagy. Curr Mol Med 13(2):252–265. https://doi.org/10.2174/156652413804810772
Steinmann C, Landsverk ML, Barral JM, Boehning D (2008) Requirement of inositol 1,4,5-trisphosphate receptors for tumor-mediated lymphocyte apoptosis. J Biol Chem 283(20):13506–13509. https://doi.org/10.1074/jbc.C800029200
Südhof TC, Newton CL, Archer BT 3rd, Ushkaryov YA, Mignery GA (1991) Structure of a novel InsP3 receptor. EMBO J 10(11):3199–3206
Sun F, Xu X, Wang X, Zhang B (2016) Regulation of autophagy by Ca2+. Tumour Biol 37:15467–15476. https://doi.org/10.1007/s13277-016-5353-y
Sung PJ, Tsai FD, Vais H, Court H, Yang J et al (2013) Phosphorylated K-Ras limits cell survival by blocking Bcl-xL sensitization of inositol trisphosphate receptors. Proc Natl Acad Sci U S A 110(51):20593–20598. https://doi.org/10.1073/pnas.1306431110
Szabadkai G, Bianchi K, Varnai P, De Stefani D, Wieckowski MR et al (2006) Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J Cell Biol 175(6):901–911. https://doi.org/10.1083/jcb.200608073
Szatkowski C, Parys JB, Ouadid-Ahidouch H, Matifat F (2010) Inositol 1,4,5-trisphosphate-induced Ca2+ signalling is involved in estradiol-induced breast cancer epithelial cell growth. Mol Cancer 9:156. https://doi.org/10.1186/1476-4598-9-156
Taylor CW, Tovey SC (2010) IP3 receptors: toward understanding their activation. Cold Spring Harb Perspect Biol 2(12):a004010. https://doi.org/10.1101/cshperspect.a004010
Taylor CW, da Fonseca PC, Morris EP (2004) IP3 receptors: the search for structure. Trends Biochem Sci 29(4):210–219. https://doi.org/10.1016/j.tibs.2004.02.010
Terry LE, Alzayady KJ, Furati E, Yule DI (2018) Inositol 1,4,5-trisphosphate receptor mutations associated with human disease. Messenger (Los Angel) 6(1–2):29–44
Thillaiappan NB, Chavda AP, Tovey SC, Prole DL, Taylor CW (2017) Ca2+ signals initiate at immobile IP3 receptors adjacent to ER-plasma membrane junctions. Nat Commun 8(1):1505. https://doi.org/10.1038/s41467-017-01644-8
Ueasilamongkol P, Khamphaya T, Guerra MT, Rodrigues MA, Gomes DA et al (2020) Type 3 inositol 1,4,5-trisphosphate receptor is increased and enhances malignant properties in cholangiocarcinoma. Hepatology 71(2):583–599. https://doi.org/10.1002/hep.30839
Urbani A, Giorgio V, Carrer A, Franchin C, Arrigoni G et al (2019) Purified F-ATP synthase forms a Ca2+-dependent high-conductance channel matching the mitochondrial permeability transition pore. Nat Commun 10(1):4341. https://doi.org/10.1038/s41467-019-12331-1
Vanderheyden V, Devogelaere B, Missiaen L, De Smedt H, Bultynck G et al (2009) Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by reversible phosphorylation and dephosphorylation. Biochim Biophys Acta 1793(6):959–970. https://doi.org/10.1016/j.bbamcr.2008.12.003
Vautrin-Glabik A, Botia B, Kischel P, Ouadid-Ahidouch H, Rodat-Despoix L (2018) IP3R3 silencing induced actin cytoskeletal reorganization through ARHGAP18/RhoA/mDia1/FAK pathway in breast cancer cell lines. Biochim Biophys Acta, Mol Cell Res 1865(7):945–958. https://doi.org/10.1016/j.bbamcr.2018.04.002
Vermassen E, Parys JB, Mauger JP (2004) Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants. Biol Cell 96(1):3–17. https://doi.org/10.1016/j.biolcel.2003.11.004
Vervloessem T, Yule DI, Bultynck G, Parys JB (2015) The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca2+-release channel. Biochim Biophys Acta 1853(9):1992–2005. https://doi.org/10.1016/j.bbamcr.2014.12.006
Vervloessem T, Akl H, Tousseyn T, De Smedt H, Parys JB et al (2017) Reciprocal sensitivity of diffuse large B-cell lymphoma cells to Bcl-2 inhibitors BIRD-2 versus venetoclax. Oncotarget 8(67):111656–111671. https://doi.org/10.18632/oncotarget.22898
Wang SH, Shih YL, Ko WC, Wei YH, Shih CM (2008) Cadmium-induced autophagy and apoptosis are mediated by a calcium signaling pathway. Cell Mol Life Sci 65(22):3640–3652. https://doi.org/10.1007/s00018-008-8383-9
White C, Li C, Yang J, Petrenko NB, Madesh M et al (2005) The endoplasmic reticulum gateway to apoptosis by Bcl-XL modulation of the InsP3R. Nat Cell Biol 7(10):1021–1028. https://doi.org/10.1038/ncb1302
Wozniak AL, Wang X, Stieren ES, Scarbrough SG, Elferink CJ et al (2006) Requirement of biphasic calcium release from the endoplasmic reticulum for Fas-mediated apoptosis. J Cell Biol 175(5):709–714. https://doi.org/10.1083/jcb.200608035
Xie Q, Xu Y, Gao W, Zhang Y, Su J et al (2018) TAT-fused IP3R-derived peptide enhances cisplatin sensitivity of ovarian cancer cells by increasing ER Ca2+ release. Int J Mol Med 41(2):809–817. https://doi.org/10.3892/ijmm.2017.3260
Yue Z, Jin S, Yang C, Levine AJ, Heintz N (2003) Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 100(25):15077–15082. https://doi.org/10.1073/pnas.2436255100
Zhong F, Harr MW, Bultynck G, Monaco G, Parys JB et al (2011) Induction of Ca2+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction. Blood 117(10):2924–2934. https://doi.org/10.1182/blood-2010-09-307405
Zhou Y, Nwokonko RM, Baraniak JH Jr, Trebak M, Lee KPK et al (2019) The remote allosteric control of Orai channel gating. PLoS Biol 17(8):e3000413. https://doi.org/10.1371/journal.pbio.3000413
Acknowledgements
Research work performed in our laboratory on this topic was supported by grants from the Research Foundation—Flanders (FWO) (G073109N, G057112N, G081913N, G063413N, G0C9114N, G092715N, G0A3416N, G090118N and G0A6919N), the Inter University Attraction Poles program P7/13 and by the Research Council of the KU Leuven (Concerted Actions G.O.A. 09/012 and grants 14/101 and C14/19/099). T.V. obtained a postdoctoral fellowship of the FWO. G.B. and J.B.P. are part of the FWO Scientific Research Network CaSign (W0.019.17N).
Conflict-of-Interest Disclosure Statement
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Parys, J.B., Bultynck, G., Vervliet, T. (2021). IP3 Receptor Biology and Endoplasmic Reticulum Calcium Dynamics in Cancer. In: Agellon, L.B., Michalak, M. (eds) Cellular Biology of the Endoplasmic Reticulum . Progress in Molecular and Subcellular Biology, vol 59. Springer, Cham. https://doi.org/10.1007/978-3-030-67696-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-67696-4_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-67695-7
Online ISBN: 978-3-030-67696-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)